Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua, Padua, Italy.
Department of Medicine, Institute of Radiology, University of Padua, Padua, Italy.
Clin Cardiol. 2022 Jun;45(6):629-640. doi: 10.1002/clc.23809. Epub 2022 Mar 30.
Although the primary cause of death in COVID-19 infection is respiratory failure, there is evidence that cardiac manifestations may contribute to overall mortality and can even be the primary cause of death. More importantly, it is recognized that COVID-19 is associated with a high incidence of thrombotic complications.
Evaluate if the coronary artery calcium (CAC) score was useful to predict in-hospital (in-H) mortality in patients with COVID-19. Secondary end-points were needed for mechanical ventilation and intensive care unit admission.
Two-hundred eighty-four patients (63, 25 years, 67% male) with proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who had a noncontrast chest computed tomography were analyzed for CAC score. Clinical and radiological data were retrieved.
Patients with CAC had a higher inflammatory burden at admission (d-dimer, p = .002; C-reactive protein, p = .002; procalcitonin, p = .016) and a higher high-sensitive cardiac troponin I (HScTnI, p = <.001) at admission and at peak. While there was no association with presence of lung consolidation and ground-glass opacities, patients with CAC had higher incidence of bilateral infiltration (p = .043) and higher in-H mortality (p = .048). On the other side, peak HScTnI >200 ng/dl was a better determinant of all outcomes in both univariate (p = <.001) and multivariate analysis (p = <.001).
The main finding of our research is that CAC was positively related to in-H mortality, but it did not completely identify all the population at risk of events in the setting of COVID-19 patients. This raises the possibility that other factors, including the presence of soft, unstable plaques, may have a role in adverse outcomes in SARS-CoV-2 infection.
虽然 COVID-19 感染的主要死亡原因是呼吸衰竭,但有证据表明心脏表现可能导致总体死亡率,甚至可能是死亡的主要原因。更重要的是,人们认识到 COVID-19 与血栓并发症的高发率有关。
评估冠状动脉钙 (CAC) 评分是否可用于预测 COVID-19 患者的住院死亡率。次要终点为需要机械通气和入住重症监护病房。
分析了 284 例经证实患有严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染的患者的非对比胸部 CT 以计算 CAC 评分。检索了临床和影像学数据。
CAC 患者入院时炎症负担更高(D-二聚体,p=0.002;C 反应蛋白,p=0.002;降钙素原,p=0.016),入院和峰值时高敏心肌肌钙蛋白 I (HScTnI) 更高(p<0.001)。虽然与肺实变和磨玻璃混浊的存在无关,但 CAC 患者双侧浸润的发生率更高(p=0.043),住院死亡率更高(p=0.048)。另一方面,在单变量(p<0.001)和多变量分析(p<0.001)中,峰值 HScTnI>200ng/dl 是所有结果的更好预测指标。
我们研究的主要发现是 CAC 与住院死亡率呈正相关,但它并未完全确定 COVID-19 患者发生事件的所有高危人群。这表明其他因素,包括不稳定的软斑块的存在,可能在 SARS-CoV-2 感染的不良结果中起作用。